Dr Ooi is an Al and Val Rosenstrauss Fellow in the School of Clinical Sciences at Monash Health.  His lab focuses on generating autoantigen-specific regulatory T cells to treat autoimmune diseases. 

During his PhD (2009) and post-doctoral training, Dr. Ooi showed that inflammatory T helper cells specific for self-proteins (known as autoantigens) underlie the pathogenesis of autoimmune disease. Now, Dr. Ooi and his team are devising regulatory T cell-based therapies that specifically switch off the autoantigen-specific inflammatory response. 

His work has been published in the top journals including in PNAS, J Clin Invest and Nature; and he has received funding from the NHMRC, Rebecca Cooper Medical Research Foundation and the Lupus Research Alliance to develop these new and innovative therapies.